NOVEL APPROACHES FOR TRANSURETHRAL EN-BLOC RESECTION OF LARGE BLADDER TUMORS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: to develop optimal techniques of en-bloc resection of large non-muscle invasive bladder tumors, determine the proper method of specimen extraction and assess the quality of specimens obtained by different techniques. Materials and methods. A total of 12 patients with primary cT1 bladder cancer underwent transurethral en-bloc resection between January 2018 and March 2019 were enrolled into the study. Tumor size ranged from 3.5 cm to 6.2 cm. For removal and extraction of large bladder tumors using thulium fiber en-bloc laser three different techniques were developed: “swiss cheese technique”, “crown and root technique” and “three steps technique” technique». The main pathologic criteria used for assessment of removal technique were tumor grade (G), depth of invasion (T), presence of carcinoma in situ (CIS), variant histology (VH), lymphovascular invasion (LVI), presence of detrusor muscle. Additional criteria were horizontal and vertical resection margin, subclassification of T1-stage and presence of focal necrosis in tumor. Results. Among the techniques developed and tested, the best quality of specimens for morphological evaluation was obtained using the combined «crown and root technique». First step is electroresection of the exophytic part of the tumor into pieces, and the next step is en-bloc laser resection (using thulium fiber or holmium laser) of the tumor base. Overall, the quality of all specimens obtained using three techniques met the current requirements of pathologic study. Summary. En-bloc resection techniques of large bladder tumors allow obtaining specimen suitable for proper morphological evaluation and correct tumor staging. Further studies are required to evaluate the impact of these techniques on long-term results of treatment options.

Full Text

Restricted Access

About the authors

D. A Kislyakov

Sechenov First Moscow State Medical University, Ministry of Health of Russia; Voskresensk district hospital №2

Email: dakislyakov@gmail.com
Ph.D. student, FGAOU VO I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia, urologist at the Voskresensk district hospital №2 Moscow Russia

L. O Severgina

Sechenov First Moscow State Medical University, Ministry of Health of Russia

MD, professor at the Department of Department of Pathology named after A.I. Strukov; pathologist at the CPAO Moscow Russia

D. G Tsarichenko

Sechenov First Moscow State Medical University, Ministry of Health of Russia

MD, professor Moscow Russia

L. M Rapoport

Sechenov First Moscow State Medical University, Ministry of Health of Russia

MD, professor Moscow Russia

I. A Korovin

Sechenov First Moscow State Medical University, Ministry of Health of Russia

5-year student Moscow Russia

N. I Sorokin

M.V. Lomonosov State University

Email: nisorokin@mail.ru
MD, professor Moscow Russia

References

  1. Gontero P., Sylvester R., Pisano F. et al. The impact of re-TUR on clinical outcomes in a large multi-centre cohort of T1-HG/G3 patients treated with BCG. BJU Int. 2016;118:44-52. doi: 10.1111/bju.13354.
  2. Francesco Soria, Giancarlo Marra, David D’Andrea, Paolo Gontero, Shahrokh F. Shariat. The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer. Transl Androl Urol. 2019;8(1):46-53. doi: 10.21037/tau.2018.10.19.
  3. EAU Guidelines on non-muscle-invasive bladder cancer (Ta, T1, CIS), 2019.
  4. Herr H.W., Donat S.M. Quality control in transurethral resection of bladder tumours. BJU Int2008;102:1242-6. Doi: 10.1111/j. 1464-410X.2008.07966.x
  5. Mariappan P., Finney S.M., Head E. et al. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across. BJU Int. 2012;109:1666-73. doi: 10.1111/j.1464-410X.2011.10571.x
  6. Maruniak N.A., Takezawa K., Murphy W.M. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol. 2002;167:2404-2407. doi: 10.1016/S0022-5347(05)64993-2.
  7. Rouprêt M., Yates D.R., Varinot J. et al. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience. Can J Urol. 2012;19:6459-6464.
  8. Kramer M.W., Rassweiler J.J., Klein J. et al. En bloc resection ofurothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33:1937-1943. doi: 10.1007/s00345-015-1568-6
  9. Bum Sik Tae, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Kyung Chul Moon, Ja Hyeon Ku. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer. PLoS One. 2017;12(12):e0189354. Doi: 10.1371/ journal.pone.0189354.
  10. Kawada T., Ebihara K., Suzuki T., Imai K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol. 1997;157(6):2225-2226.
  11. WHO Classification of tumors of the urinary system and male genital organs. Edited by Holger Moch, Peter A. Humphrey, Thomas M. Ulbright, Victor E. Reuter. International agency for research on cancer. Lyon, 2016. 356.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies